% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • andrewdude88 andrewdude88 Jun 11, 2013 2:42 AM Flag

    Do your DD; this could be a risky investment

    I don't mean to rain on the parade of recent breakout; but i think we need to cool down a bit and think about all the potential risks on ACAD. Remember Pimavanserin suppress PDP; it doesn't cure PD. The successful P3 result is based on subjective observation of few hundred patience. What the real world result would be when applied to thousands or hundreds of thousands of patients is really anyone guess. Unlike other drugs for serious disease such as cancer, Pimavanserin doesn't have a progression free or overall survival objective measure for primary end point. It concerns me that Pimavanserin result is just a subjective observation.

    Second risk is other potential, promising treatment to PD. I recent came across this article titled Cancer Drug Shows Promise for Parkinson's Disease; quote "June 6, 2013 A chemotherapy treatment for adults with leukemia may hold potential to treat people with Parkinson’s disease (PD), according to an early study published May 10 in Human Molecular Genetics. In mice, the drug was able to reduce levels of a harmful protein in the brain and improve motor symptoms. Scientists have not yet determined the drug’s potential for people living with PD, but this early study in mice offers hope." What's going to happen to ACAD stock if this gets FDA backing?

    Just like every other stock, this has risks; but all the posts i saw so far all sound like if this is a slam dunk, 100%, i will retire super rich awesome stock. Let's try some DD here. I still think this is a good long term bet; but i don't see why ACAD is getting pumped to a 2 billion company without a NDA submission, FDA approval, or any revenue.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
32.0315+1.6615(+5.47%)12:44 PMEDT